药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Hydroxytestosterone
Avatrombopag
The serum concentration of Avatrombopag can be increased when it is combined with Lemborexant.
4-Hydroxytestosterone
Duvelisib
The serum concentration of Duvelisib can be increased when it is combined with Lemborexant.
4-Hydroxytestosterone
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Lemborexant.
4-Hydroxytestosterone
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Lemborexant.
4-Hydroxytestosterone
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Lemborexant.
4-Hydroxytestosterone
Emapalumab
The metabolism of Lemborexant can be increased when combined with Emapalumab.
4-Hydroxytestosterone
Secukinumab
The metabolism of Lemborexant can be increased when combined with Secukinumab.
4-Hydroxytestosterone
Certolizumab pegol
The metabolism of Lemborexant can be increased when combined with Certolizumab pegol.
4-Hydroxytestosterone
Golimumab
The metabolism of Lemborexant can be increased when combined with Golimumab.
4-Hydroxytestosterone
Rilonacept
The metabolism of Lemborexant can be increased when combined with Rilonacept.
4-Hydroxytestosterone
Canakinumab
The metabolism of Lemborexant can be increased when combined with Canakinumab.
4-Hydroxytestosterone
Afelimomab
The metabolism of Lemborexant can be increased when combined with Afelimomab.
4-Hydroxytestosterone
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Lemborexant.
4-Hydroxytestosterone
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Lemborexant.
4-Hydroxytestosterone
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Lemborexant.
4-Hydroxytestosterone
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Lemborexant.
4-Hydroxytestosterone
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Lemborexant.
4-Hydroxytestosterone
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Lemborexant.
4-Hydroxytestosterone
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Lemborexant.
4-Hydroxytestosterone
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Lemborexant.